Article information
Abstract
Objective
To compare the clinical characteristics and outcomes of HIV-1-HTLV-1 coinfected patients, in Bahia, Brazil.
MethodsRetrospective, comparative study.
ResultsAmong a total of 123 consecutive HIV infected patients, 20 men (20.6%) and 6 women (23.1%) had detectable antibodies against HTLV-I/II. The major risk factor associated with coinfection by HTLV was intravenous drug use (57.7% of coinfected patient versus 9.2% of HTLV seronegative patients, p < 0.0001). Coinfected patients had higher absolute lymphocyte counts (1,921 + 762 versus 1,587 + 951, p = 0.03). Both groups of patients had similar means of CD4+ and CD8+ cell counts. However, among patients with AIDS CD4+ cell counts were significantly higher among those coinfected with HTLV-I/II (292 ± 92 cells/mm3, versus 140 ± 177cells/mm3, p = 0.36). The frequency and type of opportunistic infections were similar for both groups, but strongyloidiasis and encephalopathy were more frequently diagnosed in coinfected patients (p < 0.05). On the other hand, patients coinfected with HTLV-I/II received significantly less antiretroviral therapy than singly infected by HIV-1
ConclusionCoinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis for HIV patients. Higher CD4 count may lead to underestimation of immunodeficiency, and delay to initiate antiretroviral therapy.
Keywords:
HIV
HTLV-I/II
coinfection Strongyloidiasis
CD4/CD8
Full text is only aviable in PDF
References
[1.]
V.S. Kalyanaraman, M.G. Sarngadharan, T. Nakao, et al.
Natural antibodies to the structural core protein (p24) of the human t-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients.
Proc Natl Acad Sci. USA, 79 (1982), pp. 1653-1657
[2.]
M. Robert-Guroff, R.C. Gallo.
Establishment of an etiologic relationship between the human T-cell leukemia/lymphoma virus (HTLV) and adult T-cell leukemia.
Blut, 47 (1983), pp. 1-12
[3.]
A. Gessain, F. Barin, J.C. Vernanr, et al.
Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis.
Lancet, 2 (1986), pp. 99-100
[4.]
C. Bartholomew, F. Cleghorn, W. Charles, et al.
HTLV-I and tropical spastic paraparesis.
Lancet, 2 (1986), pp. 99-100
[5.]
M. Osame, K. Usuku, S. Izumo, et al.
HTLV-I associated myelopathy, a new clinical entity.
Lancet, 1 (1986), pp. 1031-1032
[6.]
K. Ocochi, H. Sato, Y. Hinuma.
A retrospective study on transmission of adult T cell leukemia virus by blood transfusion. Seroconversion in recipients.
Vox Sang, 46 (1984), pp. 245-253
[7.]
Y. Ando, S. Nakano, K. Saito, et al.
Transmission of adult T cell leukemia retrovirus (HTLV-I) from mother to child: comparison of bottle-fed with breast-fed babies.
Jpn J Cancer Res, 78 (1987), pp. 322-324
[8.]
C. Bartholomew, W.C. Saxiger, J.W. Clark, et al.
Transmission of HTVL-I and HIV among homosexual men in Trinidad.
JAMA, 257 (1987), pp. 2605-2608
[9.]
W. Kajiyama, S. Kashiwagi, H. Ikematsu, et al.
Intrafamilial transmission of adult T cell leukemia virus.
J Infect Dis, 154 (1986), pp. 851-857
[10.]
E. Delaporte, M. Peters, J.L. Bardy, et al.
Blood transfusion as a major risk factor for HTLV-I infection among hospitalized children in Gabon (Equatorial Africa).
J Acq Immune Def Syndr, 6 (1993), pp. 424-428
[11.]
W.A. Blattner.
Epidemiology of HYLV-I and associated diseases.
Human Retrovirollogy: HTLV, pp. 251-265
[12.]
C. Bartholomew, W. Blattner, F. Cleghorn.
Progression to AIDS in homosexual men coinfection with HIV and HTLV-I Trinidad.
Lancet, 2 (1987), pp. 1469-1987
[13.]
T. Hattori, A. Koito, K. Takatsuli, S. Ikematsu, et al.
Frequent infection with human T-cell lymphotropic virus type I in patients with AIDS, but not in carriers of human immunodeficiency virus type 1.
J Acq Immune Def Synd, 2 (1989), pp. 272-276
[14.]
E. Gotuzzo, J. Escamilla, I.A. Phillips, J. Sanchez, F.S. Wignall, J. Antigoni.
The impact of human T-lymphotropic virus type I/II infection on the prognosis of sexually acquired immunodeficiency syndrome.
Archives of Internal Medicine, 152 (1992), pp. 1429-1452
[15.]
M. Schechter, L.H. Harrison, N.A. Halsey, G. Trade, M. Santino, C.H. Moulton, T.C. Quinn.
Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil: impact on markers of HIV disease progression.
JAMA, 271 (1994), pp. 353-357
[16.]
C. Brites, W. Harrington Jr, C. Pedroso, E.M. Netto, R. Badaró.
Epidemiological characteristics of HTLV-I and II coinfection in Brazilian subjects infected by HIV-1.
Braz J Infect Dis, (1997), pp. 43-48
[17.]
J.A. Zack, A.J. Cann, J.P. Lugo, I.S.Y. Chen.
HIV-1 production from infected peripheral blood T cell after HTLV-I induced mitogenic stimulation.
Science, 240 (1988), pp. 1026-1029
[18.]
De Rossi A, Saggioro D, Calabró ML, Cenzato R, Chieco-Bianchi. Reciprocal activation of human T-lymphotropic viruses in HTLV-I transformed cells superinfected with HIV-1. J Acq Immune Def Synd 191; 4:380-385.
[19.]
P. Lusso, F. Lori, R.C. Gallo.
CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses.
J Virol, 64 (1990), pp. 6341-6344
[20.]
I. Dourado, L.C. Alcantara, M.L. Barreto, M. da Gloria Teixeira, B. Galvão-Castro.
HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics.
J Acquir Immune Defic Syndr, 34 (2003 15), pp. 527-531
[21.]
Ministério da Saúde. AIDS - Boletim epidemiológico 2002, Ano XVI, N0 01. Semana epidemiológica 14 a 52.
[22.]
R.B. Lal, S. Brodine, J. Kazura, E. Mbidde Katonga, R. Yanagihara, C. Roberts.
Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp 21) - spiked Western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and II infections.
J Clin Microbiol, 30 (1992), pp. 296-299
[23.]
J.J. Lipka, P. Santiago, L. Chan, G.R. Reyes, K.P. Samuel, W.A. Blattner, G.M. Shaw, C.V. Hanson, J.J. Sninsky, S.K.H. Foung.
Modified Western blot assay for confirmation and differentiation of human T-cell lymphotropic virus type I and II.
J Infect Dis, 164 (1991), pp. 400-403
[24.]
J.J. Lipka, I. Miyoshi, K.G. Hadlol, G.R. Reyes, T.P. Chow, W.A. Blattner, G.M. Shaw, C.V. Hanson, D. Gallo, L. Chan, S.K.H. Foung.
Segregation of human T-cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.
J Infect Dis, 165 (1992), pp. 268-272
[25.]
S.L. Welles, N. Tachibana, A. Okayama, et al.
Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.
Intl J Cancer, 56 (1994), pp. 337-340
[26.]
C. Brites, W. Harrington Jr, C. Pedroso, R. Badaró.
HTLV-I/II infection among HIV-1 infected individuals in Brazil.
The First National Conference on Human Retroviruses and Related Infections,
[27.]
K. Nakada, M. Kokagura, H. Komoda, Y. Hinuma.
High incidence of HTLV antibody in carriers of Strongyloides stercoralis [letter].
Lancet, 1 (1984), pp. 633
[28.]
A.C. Dixon, E.T. Yanagihara, D.W. Kwock, J.M. Nakamura.
Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
West Indian J Med, 151 (1989), pp. 410-413
[29.]
R.D. Robinson, J.F. Lindo, F.A. Neva, et al.
Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
West Indian Med J, 169 (1990), pp. 692-696
[30.]
Y. Sato, H. Toma, M. Takara, S. Kiyuna, Y. Shiroma.
Seroespidemiological studies on the concomitance of strongyloidiasis with T-cell leukemia viral infection in Okinawa, Japan.
Japanese Journal of Parasitology, 39 (1990), pp. 376-383
[31.]
G. Feitosa, A.C. Bandeira, D.P. Sampaio, R. Badaró, C. Brites.
High prevalence of giardiasis and strongyloidiasis among HIV-infected patients in Bahia, Brazil.
Braz J Infect Dis, 6 (2001), pp. 339-344
[32.]
M.R. Newton, P. Rudge, K. Cruickshank.
Magnetic resonance imaging in HTLV-I antibody positive patients.
Lancet, ii (1987),
[33.]
E. Tournier-Lasserve, D. Gout, A. Gessain, et al.
HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis.
Lancet, ii (1987), pp. 49-50
[34.]
H. Shibasaki, C. Endo, Y. Kuroda, R. Kakigi, K. Oda, S. Komine.
Clinical picture of HTLV-I associated myelopathy.
J Neurol Sci, 87 (1988), pp. 15-24
[35.]
M. Puccione-Söhler, L. Chimelli, M. Merçon, et al.
Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflamation.
J Neurol Sci, 207 (2003), pp. 87-93
[36.]
C. Brites, M. Weyll, C. Pedroso, R. Badaró.
Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-I) infection in Bahia, Brazil.
AIDS, 16 (2002), pp. 1292-1293
[37.]
M. Sobesky, P. Couppie, R. Pradinaud, et al.
Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. GECVIG (Clinical HIV Study Group in Guiana).
Presse Med, 29 (2000 Mar 4), pp. 413-416
[38.]
C. Brites, R. Alencar, R. Gusmão, et al.
Coinfection by HTLV-I is associated with a shorter survival among HIV-infected patients, in Bahia, Brazil.
AIDS, 15 (2001 Oct 19), pp. 2053-2055
[39.]
M. Schechter, L. Moulton, L. Harrison.
HIV viral load and CD4+ lymphocyte counts in subjects coinfected by HIV and HTLV-1.
J Acquir Immune Defic Syndrom Hum Retrovirol, 15 (1997), pp. 308-311
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
